Investors & Media

Corporate Profile

Abeona Therapeutics is focused on developing and delivering gene therapy products for severe and life-threatening rare diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases such as Sanfilippo syndrome, Epidermolysis Bullosa, Batten disease, Fanconi anemia and other rare disorders.

Investor & Media Contact

Christine Silverstein
Senior Vice President
Investor Relations & Finance

+1 (646) 813-4707

IR Links & Resources